Mabwell (Shanghai) Bioscience Co., Ltd.
迈威生物
Mabwell (Shanghai) Bioscience Co., Ltd.
Biotech/Healthcare
Mabwell (Shanghai) Bioscience Co., Ltd. is dedicated to the R&D and manufacturing of innovative macromolecule drugs, such as therapeutic monoclonal antibodies and long-acting recombinant proteins.
Latest round: IPO (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.